BackHims & Hers Health Overview
Hims & Hers Health Inc - Ordinary Shares - Class A

Hims & Hers Health Target Price

See Hims & Hers Health's analyst price targets ($31) vs the current share price.

Get informed when a big investor buys or sells

+ Follow

Share Price

$27.82

Average Target Price

$31.2312.3% upside

15 analysts in the last 4 months

High: $42 | Low: $23

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

DateAnalystPrice TargetCurrent Upside/Downside
2026-08-24Truist Financial$3215% upsideOpen
2026-08-20BarclaysGlen Santangelo$3525.8% upsideOpen
2026-08-11Deutsche BankGeorge Hill$266.5% downsideOpen
2026-08-11NeedhamRyan MacDonald$4251% upsideOpen
2026-08-11Morgan Stanley$280.6% upsideOpen
2026-07-09UBS$3733% upsideOpen
2026-07-01Canaccord Genuity$4043.8% upsideOpen
2026-06-17Barclays$3940.2% upsideOpen
2026-06-02Leerink PartnersMichael Cherny$2510.1% downsideOpen
2026-05-26UBS$2510.1% downsideOpen
2026-05-22UBS$2317.3% downsideOpen
2026-05-12Jefferies$24.511.9% downsideOpen
2026-05-12UBS$3525.8% upsideOpen
2026-05-12Canaccord Genuity$3215% upsideOpen
2026-05-05Deutsche BankGeorge Hill$2510.1% downsideOpen
2026-03-10Deutsche Bank$280.6% upsideOpen
2026-03-09NeedhamRyan MacDonald$307.8% upsideOpen
2026-03-09Oppenheimer$12.555.1% downsideOpen
2026-02-24Barclays$2510.1% downsideOpen
2026-02-24Morgan StanleyCraig Hettenbach$2124.5% downsideOpen
2026-02-24Evercore ISI$2413.7% downsideOpen
2026-02-24Truist FinancialJailendra Singh$1835.3% downsideOpen
2026-02-24Leerink Partners$17.537.1% downsideOpen
2026-02-10Deutsche BankGeorge Hill$3111.4% upsideOpen
2026-02-09Leerink PartnersMichael Cherny$2028.1% downsideOpen
2026-02-02BTIG$60115.7% upsideOpen
2026-01-08Wolfe Research$294.2% upsideOpen
2025-12-08Barclays$4872.5% upsideOpen
2025-12-04Leerink PartnersMichael Cherny$4147.4% upsideOpen
2025-11-12Morgan StanleyCraig Hettenbach$4043.8% upsideOpen
2025-11-04Seaport Global$59112.1% upsideOpen
2025-11-04Truist FinancialJailendra Singh$3733% upsideOpen
2025-11-04UBS$3215% upsideOpen
2025-11-04Leerink PartnersMichael Cherny$4665.3% upsideOpen
2025-06-24Truist FinancialJailendra Singh$4561.8% upsideOpen
2025-06-23UBS$307.8% upsideOpen
2025-06-04NeedhamRyan Macdonald$65133.6% upsideOpen
2025-02-19Canaccord GenuityMaria Ripps$68144.4% upsideOpen
2024-12-02Canaccord GenuityMaria Ripps$3836.6% upsideOpen
2024-11-05Piper SandlerKorinne Wolfmeyer$2124.5% downsideOpen
2024-11-05NeedhamRyan MacDonald$280.6% upsideOpen
2024-10-29Leerink PartnersMichael Cherny$266.5% downsideOpen
2024-10-21Bank of America SecuritiesMichael Cherny$2510.1% downsideOpen
2024-10-14Bank of America SecuritiesMichael Cherny$2317.3% downsideOpen
2024-10-14Truist FinancialJailendra Singh$2317.3% downsideOpen
2024-09-13Bank of America SecuritiesAllen Lutz$2028.1% downsideOpen
2024-08-27CitigroupDaniel Grosslight$2028.1% downsideOpen
2024-08-07JefferiesGlen Santangelo$1835.3% downsideOpen
2024-08-06Deutsche BankGeorge Hill$2317.3% downsideOpen
2024-05-22Canaccord GenuityMaria Ripps$2413.7% downsideOpen

Hims & Hers Health (HIMS) FAQ

Hims & Hers Health posts a target price of $31. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.

A target price of $31 for HIMS means covering analysts, on average, see the stock 12.3% upside of $27.82 over about 12 months. Dig into who set the high and low targets and how recently they updated — freshness matters as much as the average itself.

Context for HIMS's target price usually means three checks: (1) trend versus prior periods, (2) level versus peers, and (3) consistency with growth and profitability. This page covers the first two; Hims & Hers Health's other metric pages and overview cover the third.

Judging Hims & Hers Health against Consumer Staples peers is usually better than using a market-wide rule of thumb. Business models inside Consumer Staples are more comparable, which makes gaps in target price easier to interpret. Start with $31 here, then scan peer and history charts to see if the gap is persistent.